Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 30.77 | N/A |
| PEG Ratio (TTM) | 3.39 | N/A |
| P/S Ratio (TTM) | 7.12 | N/A |
| P/B Ratio (TTM) | 6.59 | N/A |
| P/FCF Ratio (TTM) | 25.41 | N/A |
| Price to 5YR AVG Earnings Ratio | 44.90 | N/A |
| Price to 5YR AVG FCF Ratio | 50.98 | N/A |
Profitability (85%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 15.41% | N/A |
| ROE (TTM) | 23.22% | N/A |
| Net Profit Margin (TTM) | 23.15% | N/A |
| ROIC 5YR AVG | 23.80% | N/A |
Growth (87%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 10.76% | 30.49% | 23.90% |
| Revenue | 6.50% | 11.16% | 12.49% |
| Net Income | 10.72% | 31.42% | 24.63% |
| Cash Flow | 6.52% | 4.75% | 42.76% |
Health (74%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.92 | N/A |
| Quick Ratio (TTM) | 1.91 | N/A |
| D/E Ratio (TTM) | 0.13 | N/A |
| Interest Coverage (TTM) | 37.59 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 12.74 | N/A |
| LTL to 5YR AVG FCF | 1.25 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.54% | N/A |